Enduring Activity - Update in Internal Medicine 2023 (RP2304C)

About the Conference
Internal medicine is expanding at a fast pace as new therapies are developed and new guidelines and standards of care are recommended across a spectrum of diseases. Busy physicians and internists are faced with the growing challenge of keeping abreast of all the advances. The annual Update in Internal Medicine conference is designed to help clinicians meet the challenge by offering state-of-the-art, practical advice on common conditions and exciting new developments.

Target Audience

This CME Conference is designed for: primary care providers, nurse practitioners, physician assistants, and specialists in Internal Medicine and Family Practice seeking updates in practical knowledge relating to patient care.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explore the appropriate indications for use of PPI in primary care and when these medications can be stopped safely.
  • List appropriate indications for thrombophilia testing in patients with first episode of venous thromboembolism.
  • Apply evidence-based approach to use of SGLT-2 and GLP-1 therapies in patients with cardiovascular or renal risk factors or disease.
  • Develop a practical approach to take an antibiotic allergy history and remove unnecessary penicillin allergy labels.
  • Understand the drivers of vaccine hesitancy and practical strategies to address concerns raised over vaccines.
  • Describe roles of abdominal imaging and genetic testing for screening and diagnosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD).
  • Develop a systematic approach to initial diagnostic workup for suspected interstitial lung disease.
  • List indications for imaging and referral to specialist for common MSK complaints.
  • Explain the roles of lifestyle management and pharmacologic therapy in patient weight management in primary care.

Additional Information

AttachmentSize
PDF icon UIM2023-CME-Handout-FINAL.pdf22.51 MB
Course summary
Available credit: 
  • 17.50 AMA
  • 17.50 Attendance
  • 1.00 Ethics
Course opens: 
05/25/2023
Course expires: 
12/15/2023
Cost:
$299.00
Rating: 
0

CLICK HERE TO VIEW CME HANDOUT  

(includes agenda, learning objectives, speaker listing, disclosures, CME-Ethics-MOC credit information, etc.)

REQUIREMENTS FOR COMPLETING THE COURSE:

  •  View the educational content presented live on April 22, 2023
  •  View the additional educational content/pre-recorded presentations, available on-demand
  •  Successfully complete the Post-Test/Quiz (75% pass rate)
  •  Complete the Course Evaluation
  •  Provide required participation information (for ABIM-MOC credit)

Once all of these requirements are fulfilled, credit hours are claimed, credits are posted to your Ethos transcript, and you may then view/download/print your certificate.

PLEASE NOTE:

  • Deadline to claim MOC credits is December 10, 2023.
  • Deadline to claim CME and Ethics credits is December 10, 2023.

 

 

Enduring Activity UT Southwestern Medical Center
Dallas, TX
United States

DISCLOSURE OF INELIGIBLE COMPANIES

It is the policy of the CME Office at The University of Texas Southwestern Medical Center to ensure balance, independence, objectivity, and scientific rigor in all directly sponsored or jointly provided educational activities.  In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and independence in Accredited Continuing Education, all persons in the position to control the content of an education activity are required to disclose all financial relationships in any amount occurring within the past 24 months with any ineligible company (any entity whose primary business is producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). UT Southwestern also considers ineligible those companies producing, marketing, selling, re-selling, or distributing healthcare products in development for future use on patients, such as healthcare product research companies.  All reported financial relationships with ineligible companies are reviewed for relevancy and then mitigated through a content review process prior to the activity (where applicable).

 

 

 

Course Director(s)

James Cutrell, MD

has no relevant financial relationships to disclose at this time.

Vlad Zaha, MD, PhD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Traci Adams, Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine

has no relevant financial relationships to disclose at this time.

Ariel Aday, MD

has no relevant financial relationships to disclose at this time.

Bethany Agusala, MD

has no relevant financial relationships to disclose at this time.

Sadia Ali, MD

has no relevant financial relationships to disclose at this time.

Jaime Almandoz, MD

has a financial relationship (Independent contractor) with NovoNordisk;.
has a financial relationship (Independent contractor) with Eli Lilly and Co;.

Anthony Bavry, MD MPH

has no relevant financial relationships to disclose at this time.

Luigino Bernabela, MD, RhMSUS

has no relevant financial relationships to disclose at this time.

Jason Clark

has no relevant financial relationships to disclose at this time.

Suzanne Cole, MD

has no relevant financial relationships to disclose at this time.

kathryn dao, MD, FACP, FACR

has a financial relationship (Independent contractor) with Bristol Myers Squibb ;.
has a financial relationship (Independent contractor) with RheumNow;.
has a financial relationship (Independent contractor) with Novartis;.

Sandeep Das, MD, MPH, MBA

has no relevant financial relationships to disclose at this time.

Kerry Dunbar, MD, PhD

has no relevant financial relationships to disclose at this time.

Tara DuVal

has no relevant financial relationships to disclose at this time.

Benjamin Elsbernd, MD

has no relevant financial relationships to disclose at this time.

Carolee Estelle, MD

has no relevant financial relationships to disclose at this time.

Kara Goss, MD

has no relevant financial relationships to disclose at this time.

Judah Gruen, Assistant Professor of Internal Medicine

has no relevant financial relationships to disclose at this time.

Nicholas Hendren

has no relevant financial relationships to disclose at this time.

Sandra Hofmann

has no relevant financial relationships to disclose at this time.

Minji Kang

has no relevant financial relationships to disclose at this time.

David Khan

has a financial relationship (Professional Services) with UpToDate;.
has a financial relationship (Financial Support) with JACI In Practice;.

Ronak Lakhia

has no relevant financial relationships to disclose at this time.

Benjamin Levine, Professor of Medicine

has no relevant financial relationships to disclose at this time.

Ildiko Lingvay, MD, MPH, MSCS

has a financial relationship (Grant Or Contract) with NovoNordisk, Pfizer, Merck, Mylan, Sanofi, Boehringer Ingelheim;.
has a financial relationship (Travel) with Novo Nordisk, Eli Lilly, Sanofi, Astra Zeneca, Boehringer-Ingelheim, Johnson and Johnson, Merck, Pfizer, Zealand Pharma;.
has a financial relationship (Independent contractor) with Novo Nordisk, Eli Lilly, Sanofi, Astra Zeneca, Boehringer-Ingelheim, Johnson and Johnson, Intercept, TARGETPharma, Merck, Pfizer, Valeritas, Zealand Pharma, Shionogi, Carmot Therapeutics, Structure Therapeutics, Bayer, and WebMD.;.

Katy Lonergan

has no relevant financial relationships to disclose at this time.

Yazan Madanat

has a financial relationship (Professional Services) with MD Education;.
has a financial relationship (Professional Services) with Sierra Oncology;.
has a financial relationship (Professional Services) with GERON;.
has a financial relationship (Professional Services) with OncLive;.
has a financial relationship (Professional Services) with Taiho;.
has a financial relationship (Professional Services) with Bluprint Pharmaceuticals;.
has a financial relationship (Professional Services) with Novartis;.
has a financial relationship (Professional Services) with Stemline Therapeutics ;.
has a financial relationship (Professional Services) with Rigel Pharmaceuticals;.
has a financial relationship (Professional Services) with Morphosys;.

Meredith McAdams, MD

has no relevant financial relationships to disclose at this time.

Mack Mitchell, MD

has a financial relationship (Stock Options) with Amygdala Neuroscience ;.
has a financial relationship (Stock) with Moderna;.
has a financial relationship (Grant Or Contract) with Durect ;.
has a financial relationship (Stock) with Abbvie;.

Alecia Nero, MD, MSCS, FACP

has a financial relationship (Independent contractor) with Global Blood Therapeutics;.
has a financial relationship (Independent contractor) with Editas Medicine;.
has a financial relationship (Independent contractor) with Novartis Pharmecutical;.
has a financial relationship (Independent contractor) with Dispersol;.

David Sher, MD, MPH

has a financial relationship (Grant Or Contract) with Varian Medical Systems;.

Madhuri Sopirala, MD, MPH, FIDSA, FACP

has no relevant financial relationships to disclose at this time.

Robert Toto

has a financial relationship (Independent contractor) with Astra-Zeneca;.
has a financial relationship (Independent contractor) with MedScape;.
has a financial relationship (Independent contractor) with Bayer;.
has a financial relationship (Employment) with Reata Pharmaceuticals;.
has a financial relationship (Independent contractor) with Boehringer-Ingelheim;.
has a financial relationship (Independent contractor) with Quest Diagnostics;.
has a financial relationship (Independent contractor) with Amgen;.
has a financial relationship (Independent contractor) with Quintiles;.
has a financial relationship (Independent contractor) with Relypsa;.

CONTINUING MEDICAL EDUCATION

Accreditation Statement

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statements

The University of Texas Southwestern Medical Center designates this live educational activity for a maximum of 17.5 AMA PRA Category1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for 17.5 AMA PRA Category 1 Credit™.

 

ETHICS

The University of Texas Southwestern Medical Center designates the on-demand presentation, "Communication: A High Risk Procedure" for a maximum of 1.0 hours in medical ethics and/or professional responsibility.


ABIM - MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity enables  the participant to earn up to 17.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of  Certification (MOC) program.  Participants will earn MOC points claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to  ACCME for the purpose of granting ABIM MOC points. 

Available Credit

  • 17.50 AMA
  • 17.50 Attendance
  • 1.00 Ethics

Price

Cost:
$299.00
Please login or create an account to take this course.

Registration

To register:

  1. Login to your existing account or create an account in EthosCE, online learning management system, by selecting the "create an account" link.
  2. Once logged in, return to this course page, select the designated fee and click the "add to cart" button.
  3. In the following "checkout" pages you will verify and process your payment.
  4. After registration is completed, a confirmation will be sent by email.